Century Therapeutics Inc. (NASDAQ: IPSC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CENTURY THERAPEUTICS INC.

Century Therapeutics Inc. (NASDAQ: IPSC)
Listen to this Section


$2.09
-0.1150 ( -5.23% ) 1.2M

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

Clinical Trial Pipeline Stages


Drug Name Stage
CNTY-101DetailsCancer, Relapsed/ refractory lymphoma Phase 1
CNTY-101DetailsSystemic lupus erythematosus Phase 1

Market Data


Open $2.09
Previous Close $2.20
Volume 1.2M
Market Cap $373.33M
Day Range $1.99 - $2.29
52 Week Range $0.44 - $3.04
Shares Outstanding 180.36M
Change % -5.23%
Net Change ▼ -0.1150
Insider Ownership -0.04%
Exchange NASDAQ
SectorHealthcare
IndustryMedicinal Chemicals and Botanical Products
IPO Year2021
CountryUnited States
UnderwriterJ.P. Morgan, BofA Securities, Leerink Partners, Piper Sandler, more

Insider Ownership Transactions

Total Amount Purchased: -1,696,746.00

Date Type Amount Purchased Purchaser
2024-03-18 Sale -17425.00 Pfeiffenberger Brent
2024-03-11 Sale -24000.00 Farid Adrienne
2024-03-11 Sale -24000.00 Levitsky Hyam
2024-03-11 Sale -24000.00 Russotti Gregory
2024-03-11 Sale -14000.00 Carr Douglas
2024-03-08 Sale -30684.00 Farid Adrienne
2024-02-21 Sale -485.00 Farid Adrienne
2024-02-07 Sale -643.00 Carr Douglas
2024-02-07 Sale -2035.00 Farid Adrienne
2023-12-06 Sale -1173775.00 Pfeiffenberger Brent

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 14, 2025
10-q Quarterly Reports 88 Nov 13, 2025
8-k 8K-related 49 Nov 13, 2025
4 Insider transactions 1 Nov 05, 2025
4 Insider transactions 1 Sep 22, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
4 Insider transactions 1 Sep 10, 2025
8-k 8K-related 12 Aug 29, 2025
4 Insider transactions 1 Aug 18, 2025

Latest News


× Before browsing our site, please accept our cookies policy